← Leaderboards
Bishoy Morris Faltas
Weill Medical Coll Of Cornell Univ
$1,464,409
Attributed
$1,464,409
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $516K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,464,409 · 1
By mechanism
R37$1,464,409 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Pengbo Zhou$14,509,570
- Sandra Shin$1,000,502
- Steven Monroe Lipkin$27,661,021
- Lukas Edward Dow$10,323,278
- Olivier Elemento$10,592,678
Others in their field
Other Rising Stars on “Biomarker Identification”
- Mariet Allen · Mayo Clinic Jacksonville$9,602,417
- Clifton L Dalgard · University Of Miami School Of Medicine$4,115,146
- Michael J Howell · University Of Minnesota$3,826,379
- Robert Pease Smith · Tufts University Boston$3,652,652
- Eytan Stein · Sloan-Kettering Inst Can Research$3,114,721
- Suna Onengut · University Of Virginia$3,014,326
Research focus
Biomarker IdentificationCancer CellCell LineCellsCessation Of LifeCharacteristicsClinical BiomarkersClinical RiskClinical TrialsCo-Clinical TrialCytidineCytidine DeaminaseDeaminationDecision MakingDe Novo MutationDiagnosisDna Double Strand BreakDrug ResistanceEvolutionFamilyFgfr3 GeneFutureGenesBar Codes
Grant awards (3)
Targeting APOBEC3A-induced genetic heterogeneity and drug resistance in bladder cancer$482,007
R37 · FY2025 · CA · contact PI
Targeting APOBEC3A-induced genetic heterogeneity and drug resistance in bladder cancer$466,426
R37 · FY2024 · CA · contact PI
Targeting APOBEC3A-induced genetic heterogeneity and drug resistance in bladder cancer$515,976
R37 · FY2023 · CA · contact PI